Insider Transactions in Q1 2023 at Relay Therapeutics, Inc. (RLAY)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 27
2023
|
Thomas Catinazzo Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
347
-0.23%
|
$5,205
$15.36 P/Share
|
|
Mar 27
2023
|
Peter Rahmer |
SELL
Open market or private sale
|
Direct |
297
-0.19%
|
$4,455
$15.36 P/Share
|
|
Mar 27
2023
|
Brian Adams Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
347
-0.26%
|
$5,205
$15.36 P/Share
|
|
Mar 27
2023
|
Donald A Bergstrom President, R&D |
SELL
Open market or private sale
|
Direct |
763
-0.31%
|
$11,445
$15.36 P/Share
|
|
Feb 09
2023
|
Sanjiv Patel President and CEO |
SELL
Open market or private sale
|
Direct |
14,000
-100.0%
|
$280,000
$20.55 P/Share
|
|
Feb 09
2023
|
Sanjiv Patel President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
14,000
+50.0%
|
$70,000
$5.04 P/Share
|
|
Feb 08
2023
|
Sanjiv Patel President and CEO |
SELL
Open market or private sale
|
Direct |
14,000
-100.0%
|
$280,000
$20.98 P/Share
|
|
Feb 08
2023
|
Sanjiv Patel President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
14,000
+50.0%
|
$70,000
$5.04 P/Share
|
|
Feb 07
2023
|
Sanjiv Patel President and CEO |
SELL
Open market or private sale
|
Direct |
14,000
-100.0%
|
$294,000
$21.45 P/Share
|
|
Feb 07
2023
|
Sanjiv Patel President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
14,000
+50.0%
|
$70,000
$5.04 P/Share
|
|
Jan 30
2023
|
Peter Rahmer |
SELL
Open market or private sale
|
Direct |
740
-0.46%
|
$15,540
$21.56 P/Share
|
|
Jan 30
2023
|
Donald A Bergstrom President, R&D |
SELL
Open market or private sale
|
Direct |
1,429
-0.58%
|
$30,009
$21.56 P/Share
|
|
Jan 30
2023
|
Thomas Catinazzo Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
864
-0.57%
|
$18,144
$21.56 P/Share
|
|
Jan 30
2023
|
Brian Adams Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
864
-0.63%
|
$18,144
$21.56 P/Share
|
|
Jan 19
2023
|
Sanjiv Patel President and CEO |
SELL
Open market or private sale
|
Direct |
28,000
-9.91%
|
$560,000
$20.02 P/Share
|
|
Jan 19
2023
|
Sanjiv Patel President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
28,000
+9.02%
|
$140,000
$5.04 P/Share
|
|
Jan 18
2023
|
Sanjiv Patel President and CEO |
SELL
Open market or private sale
|
Direct |
28,000
-9.91%
|
$560,000
$20.87 P/Share
|
|
Jan 18
2023
|
Sanjiv Patel President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
28,000
+9.02%
|
$140,000
$5.04 P/Share
|
|
Jan 17
2023
|
Peter Rahmer |
BUY
Grant, award, or other acquisition
|
Direct |
97,630
+38.0%
|
-
|
|
Jan 17
2023
|
Brian Adams Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
85,425
+38.41%
|
-
|
|
Jan 17
2023
|
Thomas Catinazzo Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
101,115
+40.05%
|
-
|
|
Jan 17
2023
|
Sanjiv Patel President and CEO |
SELL
Open market or private sale
|
Direct |
28,000
-9.91%
|
$560,000
$20.23 P/Share
|
|
Jan 17
2023
|
Sanjiv Patel President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
28,000
+9.02%
|
$140,000
$5.04 P/Share
|
|
Jan 17
2023
|
Donald A Bergstrom President, R&D |
BUY
Grant, award, or other acquisition
|
Direct |
160,390
+39.44%
|
-
|
|
Jan 12
2023
|
Brian Adams Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
9,994
-16.24%
|
$199,880
$20.0 P/Share
|